0001104659-17-039960.txt : 20170616
0001104659-17-039960.hdr.sgml : 20170616
20170616165709
ACCESSION NUMBER: 0001104659-17-039960
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170614
FILED AS OF DATE: 20170616
DATE AS OF CHANGE: 20170616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics AG
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: C4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LEBERSTRASSE 20
CITY: VIENNA
STATE: C4
ZIP: 1110
BUSINESS PHONE: 43 (0)1 740 93-0
MAIL ADDRESS:
STREET 1: LEBERSTRASSE 20
CITY: VIENNA
STATE: C4
ZIP: 1110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crotty Robert
CENTRAL INDEX KEY: 0001600253
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 17916748
MAIL ADDRESS:
STREET 1: 1301 2ND AVE
CITY: SEATTLE
STATE: WA
ZIP: 98101
3
1
a3.xml
3
X0206
3
2017-06-14
1
0001641640
Nabriva Therapeutics AG
NBRV
0001600253
Crotty Robert
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
General Counsel & Corp Sec.
No securities are beneficially owned.
/s/ Robert Crotty
2017-06-16